23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Innovent Biologics, Inc. › 2025-2026

Innovent Biologics, Inc. 2025-2026 Proxy Voting Records

At Innovent Biologics, Inc.'s shareholder meeting held June 24, 2026, in the 2025-2026 proxy season, 65 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,597 separate fund positions. Their filings are grouped here into 27 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — Accept Financial Statements and Statutory Reports — the reporting funds cast 100% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings. Page generated November 8, 2026.

  • 27Reported items
  • 65Asset managers
  • 1,597Fund votes
  • June 24, 2026Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from Innovent Biologics, Inc. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore Innovent Biologics, Inc. in the interactive database Compare manager voting policies

How asset managers voted at the Innovent Biologics, Inc. 2025-2026 meeting

Each item below shows how the 65 asset managers that disclosed a Innovent Biologics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Innovent Biologics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Joyce I-Yin Hsu as Director

No official resultsDIRECTOR ELECTIONS

99.9% of fund votes cast · no official result

FOR
Details: votes by 46 asset managers

The 46 asset managers below reported 160,765,527 for, 27,500 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 160,765,527AGAINST: 27,500
Largest asset managers voting on “Elect Joyce I-Yin Hsu as Director” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard51,616,0860 00For
BlackRock29,200,5000 00For
Capital Group23,425,8730 00For
EUPAC FUND20,115,0000 00For
Fidelity18,936,8250 00For
American Century3,619,0000 00For
TIAA2,552,3100 00For
State Street2,512,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,547,0000 00For
Dimensional1,341,0000 00For
TEMPLETON EMERGING MARKETS EQUITY FUND545,7550 00For
WisdomTree484,7000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
EMERGING MARKETS EQUITIES FUND INC413,9000 00For
Northern Trust407,9000 00For
AQR398,0000 00For
JPMorgan352,0000 00For
Lazard337,5000 00For
Ashmore Funds327,7060 00For
Empower323,0000 00For
GuideStone263,5000 00For
Franklin Templeton245,9830 00For
MASTER INVESTMENT PORTFOLIO237,0000 00For
AIG/SunAmerica235,0000 00For
Lincoln Financial154,5000 00For

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

2. Elect Ronald Hao Xi Ede as Director

No official resultsDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: votes by 46 asset managers

The 46 asset managers below reported 160,793,027 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 160,793,027
Largest asset managers voting on “Elect Ronald Hao Xi Ede as Director” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard51,616,0860 00For
BlackRock29,200,5000 00For
Capital Group23,425,8730 00For
EUPAC FUND20,115,0000 00For
Fidelity18,936,8250 00For
American Century3,619,0000 00For
TIAA2,552,3100 00For
State Street2,512,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,547,0000 00For
Dimensional1,341,0000 00For
TEMPLETON EMERGING MARKETS EQUITY FUND545,7550 00For
WisdomTree484,7000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
EMERGING MARKETS EQUITIES FUND INC413,9000 00For
Northern Trust407,9000 00For
AQR398,0000 00For
JPMorgan352,0000 00For
Lazard337,5000 00For
Ashmore Funds327,7060 00For
Empower323,0000 00For
GuideStone263,5000 00For
Franklin Templeton245,9830 00For
MASTER INVESTMENT PORTFOLIO237,0000 00For
AIG/SunAmerica235,0000 00For
Lincoln Financial154,5000 00For

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

3. Elect Stephen A. Sherwin as Director

No official resultsDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: votes by 46 asset managers

The 46 asset managers below reported 160,793,027 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 160,793,027
Largest asset managers voting on “Elect Stephen A. Sherwin as Director” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard51,616,0860 00For
BlackRock29,200,5000 00For
Capital Group23,425,8730 00For
EUPAC FUND20,115,0000 00For
Fidelity18,936,8250 00For
American Century3,619,0000 00For
TIAA2,552,3100 00For
State Street2,512,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,547,0000 00For
Dimensional1,341,0000 00For
TEMPLETON EMERGING MARKETS EQUITY FUND545,7550 00For
WisdomTree484,7000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
EMERGING MARKETS EQUITIES FUND INC413,9000 00For
Northern Trust407,9000 00For
AQR398,0000 00For
JPMorgan352,0000 00For
Lazard337,5000 00For
Ashmore Funds327,7060 00For
Empower323,0000 00For
GuideStone263,5000 00For
Franklin Templeton245,9830 00For
MASTER INVESTMENT PORTFOLIO237,0000 00For
AIG/SunAmerica235,0000 00For
Lincoln Financial154,5000 00For

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

4. TO RE-ELECT DR. STEPHEN A. SHERWIN AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR OF THE COMPANY

No official resultsDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: votes by 14 asset managers

The 14 asset managers below reported 18,019,583 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 18,019,583
Largest asset managers voting on “TO RE-ELECT DR. STEPHEN A. SHERWIN AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR OF THE COMPANY” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,300,0000 00For
BlackRock1,699,0000 00For
BAILLIE GIFFORD FUNDS1,330,5000 00For
Krane Shares Trust593,5000 00For
John Hancock338,5210 00For
Touchstone ETF Trust224,8740 00For
Jackson National219,5000 00For
Roundhill ETF Trust193,5000 00For
SP Funds Trust28,6000 00For
Rayliant Funds Trust25,3620 00For
WILSHIRE MUTUAL FUNDS INC23,5000 00For
Amplify ETF Trust20,0000 00For
Innovator ETFs Trust17,5000 00For
GPS Funds I5,2260 00For

5. TO RE-ELECT MR. RONALD HAO XI EDE AS AN EXECUTIVE DIRECTOR OF THE COMPANY

No official resultsDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: votes by 14 asset managers

The 14 asset managers below reported 18,019,583 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 18,019,583
Largest asset managers voting on “TO RE-ELECT MR. RONALD HAO XI EDE AS AN EXECUTIVE DIRECTOR OF THE COMPANY” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,300,0000 00For
BlackRock1,699,0000 00For
BAILLIE GIFFORD FUNDS1,330,5000 00For
Krane Shares Trust593,5000 00For
John Hancock338,5210 00For
Touchstone ETF Trust224,8740 00For
Jackson National219,5000 00For
Roundhill ETF Trust193,5000 00For
SP Funds Trust28,6000 00For
Rayliant Funds Trust25,3620 00For
WILSHIRE MUTUAL FUNDS INC23,5000 00For
Amplify ETF Trust20,0000 00For
Innovator ETFs Trust17,5000 00For
GPS Funds I5,2260 00For

6. TO RE-ELECT MS. JOYCE I-YIN HSU AS AN INDEPENDENT NON- EXECUTIVE DIRECTOR OF THE COMPANY

No official resultsDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

95% of fund votes cast · no official result

FOR
Details: votes by 14 asset managers

The 14 asset managers below reported 17,177,709 for, 841,874 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 17,177,709AGAINST: 841,874
Largest asset managers voting on “TO RE-ELECT MS. JOYCE I-YIN HSU AS AN INDEPENDENT NON- EXECUTIVE DIRECTOR OF THE COMPANY” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,300,0000 00For
BlackRock1,699,0000 00For
BAILLIE GIFFORD FUNDS1,330,5000 00For
Krane Shares Trust0593,500 00Against
John Hancock338,5210 00For
Touchstone ETF Trust0224,874 00Against
Jackson National219,5000 00For
Roundhill ETF Trust193,5000 00For
SP Funds Trust28,6000 00For
Rayliant Funds Trust25,3620 00For
WILSHIRE MUTUAL FUNDS INC023,500 00Against
Amplify ETF Trust20,0000 00For
Innovator ETFs Trust17,5000 00For
GPS Funds I5,2260 00For

7. Elect Joyce HSU I-Yin

No official resultsDIRECTOR ELECTIONS

76% of fund votes cast · no official result

FORAGAINST
Details: votes by 8 asset managers

The 8 asset managers below reported 8,431,528 for, 2,712,222 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 8,431,528AGAINST: 2,712,222
Largest asset managers voting on “Elect Joyce HSU I-Yin” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford4,970,500288,400 00Mixed
Prudential/PGIM2,311,0285,500 00For
Charles Schwab01,922,322 00Against
Fidelity1,150,0000 00For
Russell Investments0400,000 00Against
SEI044,500 00Against
Venerable Variable Insurance Trust039,500 00Against
Neuberger Berman012,000 00Against

8. Elect Ronald EDE Hao Xi

No official resultsDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: votes by 8 asset managers

The 8 asset managers below reported 11,143,750 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 11,143,750
Largest asset managers voting on “Elect Ronald EDE Hao Xi” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford5,258,9000 00For
Prudential/PGIM2,316,5280 00For
Charles Schwab1,922,3220 00For
Fidelity1,150,0000 00For
Russell Investments400,0000 00For
SEI44,5000 00For
Venerable Variable Insurance Trust39,5000 00For
Neuberger Berman12,0000 00For

9. Elect Stephen A. Sherwin

No official resultsDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: votes by 8 asset managers

The 8 asset managers below reported 11,143,750 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 11,143,750
Largest asset managers voting on “Elect Stephen A. Sherwin” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford5,258,9000 00For
Prudential/PGIM2,316,5280 00For
Charles Schwab1,922,3220 00For
Fidelity1,150,0000 00For
Russell Investments400,0000 00For
SEI44,5000 00For
Venerable Variable Insurance Trust39,5000 00For
Neuberger Berman12,0000 00For

10. Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights

No official resultsCAPITAL STRUCTURE

74% of fund votes cast · no official result

FORAGAINST
Details: votes by 46 asset managers

The 46 asset managers below reported 119,738,359 for, 41,054,668 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 119,738,359AGAINST: 41,054,668
Largest asset managers voting on “Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard51,616,0860 00For
BlackRock29,126,00074,500 00For
Capital Group18,045,3735,380,500 00Mixed
EUPAC FUND20,115,0000 00For
Fidelity318,50018,618,325 00Against
American Century03,619,000 00Against
TIAA02,552,310 00Against
State Street02,512,000 00Against
MATTHEWS INTERNATIONAL FUNDS01,547,000 00Against
Dimensional01,341,000 00Against
TEMPLETON EMERGING MARKETS EQUITY FUND0545,755 00Against
WisdomTree0484,700 00Against
TEMPLETON DRAGON FUND INC0452,519 00Against
EMERGING MARKETS EQUITIES FUND INC413,9000 00For
Northern Trust0407,900 00Against
AQR0398,000 00Against
JPMorgan0352,000 00Against
Lazard0337,500 00Against
Ashmore Funds0327,706 00Against
Empower0323,000 00Against
GuideStone0263,500 00Against
Franklin Templeton0245,983 00Against
MASTER INVESTMENT PORTFOLIO93,000144,000 00Mixed
AIG/SunAmerica0235,000 00Against
Lincoln Financial0154,500 00Against

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

11. Authorize Reissuance of Repurchased Shares

No official resultsCAPITAL STRUCTURE

32% of fund votes cast · no official result

FORAGAINST
Details: votes by 46 asset managers

The 46 asset managers below reported 51,626,586 for, 109,166,441 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 51,626,586AGAINST: 109,166,441
Largest asset managers voting on “Authorize Reissuance of Repurchased Shares” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard51,616,0860 00For
BlackRock029,200,500 00Against
Capital Group023,425,873 00Against
EUPAC FUND020,115,000 00Against
Fidelity018,936,825 00Against
American Century03,619,000 00Against
TIAA02,552,310 00Against
State Street02,512,000 00Against
MATTHEWS INTERNATIONAL FUNDS01,547,000 00Against
Dimensional01,341,000 00Against
TEMPLETON EMERGING MARKETS EQUITY FUND0545,755 00Against
WisdomTree0484,700 00Against
TEMPLETON DRAGON FUND INC0452,519 00Against
EMERGING MARKETS EQUITIES FUND INC0413,900 00Against
Northern Trust0407,900 00Against
AQR0398,000 00Against
JPMorgan0352,000 00Against
Lazard0337,500 00Against
Ashmore Funds0327,706 00Against
Empower0323,000 00Against
GuideStone0263,500 00Against
Franklin Templeton0245,983 00Against
MASTER INVESTMENT PORTFOLIO0237,000 00Against
AIG/SunAmerica0235,000 00Against
Lincoln Financial0154,500 00Against

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

12. Authorize Repurchase of Issued Share Capital

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: votes by 46 asset managers

The 46 asset managers below reported 160,793,027 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 160,793,027
Largest asset managers voting on “Authorize Repurchase of Issued Share Capital” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard51,616,0860 00For
BlackRock29,200,5000 00For
Capital Group23,425,8730 00For
EUPAC FUND20,115,0000 00For
Fidelity18,936,8250 00For
American Century3,619,0000 00For
TIAA2,552,3100 00For
State Street2,512,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,547,0000 00For
Dimensional1,341,0000 00For
TEMPLETON EMERGING MARKETS EQUITY FUND545,7550 00For
WisdomTree484,7000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
EMERGING MARKETS EQUITIES FUND INC413,9000 00For
Northern Trust407,9000 00For
AQR398,0000 00For
JPMorgan352,0000 00For
Lazard337,5000 00For
Ashmore Funds327,7060 00For
Empower323,0000 00For
GuideStone263,5000 00For
Franklin Templeton245,9830 00For
MASTER INVESTMENT PORTFOLIO237,0000 00For
AIG/SunAmerica235,0000 00For
Lincoln Financial154,5000 00For

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

13. To extend the general mandate granted to the directors to issue shares of the company by adding thereto the total…

No official resultsCAPITAL STRUCTURE

82% of fund votes cast · no official result

FORAGAINST
Details: description as filed, votes by 14 asset managers

Description as filed by funds: TO EXTEND THE GENERAL MANDATE GRANTED TO THE DIRECTORS TO ISSUE SHARES OF THE COMPANY BY ADDING THERETO THE TOTAL NUMBER OF THE SHARES TO BE BOUGHT BACK BY THE COMPANY (EXCLUDING ANY SHARES THAT ARE HELD AS TREASURY SHARES, IF ANY)

The 14 asset managers below reported 14,704,462 for, 3,315,121 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 14,704,462AGAINST: 3,315,121
Largest asset managers voting on “TO EXTEND THE GENERAL MANDATE GRANTED TO THE DIRECTORS TO ISSUE SHARES OF THE COMPANY BY ADDING THERETO THE TO” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,300,0000 00For
BlackRock01,699,000 00Against
BAILLIE GIFFORD FUNDS1,330,5000 00For
Krane Shares Trust0593,500 00Against
John Hancock0338,521 00Against
Touchstone ETF Trust0224,874 00Against
Jackson National0219,500 00Against
Roundhill ETF Trust0193,500 00Against
SP Funds Trust28,6000 00For
Rayliant Funds Trust25,3620 00For
WILSHIRE MUTUAL FUNDS INC023,500 00Against
Amplify ETF Trust20,0000 00For
Innovator ETFs Trust017,500 00Against
GPS Funds I05,226 00Against

14. To Grant a general mandate to the directors to allot, issue and deal with additional shares of the company (excluding…

No official resultsCAPITAL STRUCTURE

91% of fund votes cast · no official result

FOR
Details: description as filed, votes by 14 asset managers

Description as filed by funds: TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY (EXCLUDING ANY SHARES THAT ARE HELD AS TREASURY SHARES, IF ANY)

The 14 asset managers below reported 16,380,462 for, 1,639,121 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 16,380,462AGAINST: 1,639,121
Largest asset managers voting on “TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY (EX” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,300,0000 00For
BlackRock1,676,00023,000 00For
BAILLIE GIFFORD FUNDS1,330,5000 00For
Krane Shares Trust0593,500 00Against
John Hancock0338,521 00Against
Touchstone ETF Trust0224,874 00Against
Jackson National0219,500 00Against
Roundhill ETF Trust0193,500 00Against
SP Funds Trust28,6000 00For
Rayliant Funds Trust25,3620 00For
WILSHIRE MUTUAL FUNDS INC023,500 00Against
Amplify ETF Trust20,0000 00For
Innovator ETFs Trust017,500 00Against
GPS Funds I05,226 00Against

15. To Grant a general mandate to the directors to BUY back shares of the company (excluding any shares that are held as…

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 14 asset managers

Description as filed by funds: TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO BUY BACK SHARES OF THE COMPANY (EXCLUDING ANY SHARES THAT ARE HELD AS TREASURY SHARES, IF ANY)

The 14 asset managers below reported 18,019,583 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 18,019,583
Largest asset managers voting on “TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO BUY BACK SHARES OF THE COMPANY (EXCLUDING ANY SHARES THAT ARE H” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,300,0000 00For
BlackRock1,699,0000 00For
BAILLIE GIFFORD FUNDS1,330,5000 00For
Krane Shares Trust593,5000 00For
John Hancock338,5210 00For
Touchstone ETF Trust224,8740 00For
Jackson National219,5000 00For
Roundhill ETF Trust193,5000 00For
SP Funds Trust28,6000 00For
Rayliant Funds Trust25,3620 00For
WILSHIRE MUTUAL FUNDS INC23,5000 00For
Amplify ETF Trust20,0000 00For
Innovator ETFs Trust17,5000 00For
GPS Funds I5,2260 00For

16. Authority to Issue Repurchased Shares

No official resultsCAPITAL STRUCTURE

21% of fund votes cast · no official result

FORAGAINST
Details: votes by 8 asset managers

The 8 asset managers below reported 2,316,528 for, 8,827,222 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,316,528AGAINST: 8,827,222
Largest asset managers voting on “Authority to Issue Repurchased Shares” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford05,258,900 00Against
Prudential/PGIM2,316,5280 00For
Charles Schwab01,922,322 00Against
Fidelity01,150,000 00Against
Russell Investments0400,000 00Against
SEI044,500 00Against
Venerable Variable Insurance Trust039,500 00Against
Neuberger Berman012,000 00Against

17. Authority to Issue Shares w/o Preemptive Rights

No official resultsCAPITAL STRUCTURE

21% of fund votes cast · no official result

FORAGAINST
Details: votes by 8 asset managers

The 8 asset managers below reported 2,311,028 for, 8,832,722 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,311,028AGAINST: 8,832,722
Largest asset managers voting on “Authority to Issue Shares w/o Preemptive Rights” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford05,258,900 00Against
Prudential/PGIM2,311,0285,500 00For
Charles Schwab01,922,322 00Against
Fidelity01,150,000 00Against
Russell Investments0400,000 00Against
SEI044,500 00Against
Venerable Variable Insurance Trust039,500 00Against
Neuberger Berman012,000 00Against

18. Authority to Repurchase Shares

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: votes by 8 asset managers

The 8 asset managers below reported 11,143,750 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 11,143,750
Largest asset managers voting on “Authority to Repurchase Shares” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford5,258,9000 00For
Prudential/PGIM2,316,5280 00For
Charles Schwab1,922,3220 00For
Fidelity1,150,0000 00For
Russell Investments400,0000 00For
SEI44,5000 00For
Venerable Variable Insurance Trust39,5000 00For
Neuberger Berman12,0000 00For

19. Accept Financial Statements and Statutory Reports

No official resultsCORPORATE GOVERNANCE

100% of fund votes cast · no official result

FOR
Details: votes by 46 asset managers

The 46 asset managers below reported 160,793,027 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 160,793,027
Largest asset managers voting on “Accept Financial Statements and Statutory Reports” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard51,616,0860 00For
BlackRock29,200,5000 00For
Capital Group23,425,8730 00For
EUPAC FUND20,115,0000 00For
Fidelity18,936,8250 00For
American Century3,619,0000 00For
TIAA2,552,3100 00For
State Street2,512,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,547,0000 00For
Dimensional1,341,0000 00For
TEMPLETON EMERGING MARKETS EQUITY FUND545,7550 00For
WisdomTree484,7000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
EMERGING MARKETS EQUITIES FUND INC413,9000 00For
Northern Trust407,9000 00For
AQR398,0000 00For
JPMorgan352,0000 00For
Lazard337,5000 00For
Ashmore Funds327,7060 00For
Empower323,0000 00For
GuideStone263,5000 00For
Franklin Templeton245,9830 00For
MASTER INVESTMENT PORTFOLIO237,0000 00For
AIG/SunAmerica235,0000 00For
Lincoln Financial154,5000 00For

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

20. Accounts and Reports

No official resultsCORPORATE GOVERNANCE

100% of fund votes cast · no official result

FOR
Details: votes by 8 asset managers

The 8 asset managers below reported 11,143,750 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 11,143,750
Largest asset managers voting on “Accounts and Reports” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford5,258,9000 00For
Prudential/PGIM2,316,5280 00For
Charles Schwab1,922,3220 00For
Fidelity1,150,0000 00For
Russell Investments400,0000 00For
SEI44,5000 00For
Venerable Variable Insurance Trust39,5000 00For
Neuberger Berman12,0000 00For

21. Authorize Board to Fix Remuneration of Directors

93% of fund votes cast · no official result

FOR
Details: votes by 46 asset managers

The 46 asset managers below reported 149,775,900 for, 11,017,127 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 149,775,900AGAINST: 11,017,127
Largest asset managers voting on “Authorize Board to Fix Remuneration of Directors” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard51,616,0860 00For
BlackRock29,200,5000 00For
Capital Group23,425,8730 00For
EUPAC FUND20,115,0000 00For
Fidelity7,931,99711,004,828 00Mixed
American Century3,619,0000 00For
TIAA2,552,3100 00For
State Street2,512,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,547,0000 00For
Dimensional1,341,0000 00For
TEMPLETON EMERGING MARKETS EQUITY FUND545,7550 00For
WisdomTree484,7000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
EMERGING MARKETS EQUITIES FUND INC413,9000 00For
Northern Trust407,9000 00For
AQR398,0000 00For
JPMorgan352,0000 00For
Lazard337,5000 00For
Ashmore Funds327,7060 00For
Empower323,0000 00For
GuideStone263,5000 00For
Franklin Templeton245,9830 00For
MASTER INVESTMENT PORTFOLIO237,0000 00For
AIG/SunAmerica235,0000 00For
Lincoln Financial154,5000 00For

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

22. To authorise the board of directors of the company (the board) to fix the remuneration of the directors

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 14 asset managers

Description as filed by funds: TO AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY (THE BOARD) TO FIX THE REMUNERATION OF THE DIRECTORS

The 14 asset managers below reported 18,019,583 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 18,019,583
Largest asset managers voting on “TO AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY (THE BOARD) TO FIX THE REMUNERATION OF THE DIRECTORS” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,300,0000 00For
BlackRock1,699,0000 00For
BAILLIE GIFFORD FUNDS1,330,5000 00For
Krane Shares Trust593,5000 00For
John Hancock338,5210 00For
Touchstone ETF Trust224,8740 00For
Jackson National219,5000 00For
Roundhill ETF Trust193,5000 00For
SP Funds Trust28,6000 00For
Rayliant Funds Trust25,3620 00For
WILSHIRE MUTUAL FUNDS INC23,5000 00For
Amplify ETF Trust20,0000 00For
Innovator ETFs Trust17,5000 00For
GPS Funds I5,2260 00For

23. Directors' Fees

100% of fund votes cast · no official result

FOR
Details: votes by 8 asset managers

The 8 asset managers below reported 11,143,750 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 11,143,750
Largest asset managers voting on “Directors' Fees” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford5,258,9000 00For
Prudential/PGIM2,316,5280 00For
Charles Schwab1,922,3220 00For
Fidelity1,150,0000 00For
Russell Investments400,0000 00For
SEI44,5000 00For
Venerable Variable Insurance Trust39,5000 00For
Neuberger Berman12,0000 00For

24. Approve Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration

No official resultsAUDIT-RELATED

87% of fund votes cast · no official result

FOR
Details: votes by 46 asset managers

The 46 asset managers below reported 140,290,497 for, 20,502,530 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 140,290,497AGAINST: 20,502,530
Largest asset managers voting on “Approve Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard51,616,0860 00For
BlackRock29,126,00074,500 00For
Capital Group23,425,8730 00For
EUPAC FUND20,115,0000 00For
Fidelity11,323,3287,613,497 00Mixed
American Century03,619,000 00Against
TIAA2,552,3100 00For
State Street02,512,000 00Against
MATTHEWS INTERNATIONAL FUNDS1,547,0000 00For
Dimensional01,341,000 00Against
TEMPLETON EMERGING MARKETS EQUITY FUND0545,755 00Against
WisdomTree0484,700 00Against
TEMPLETON DRAGON FUND INC0452,519 00Against
EMERGING MARKETS EQUITIES FUND INC413,9000 00For
Northern Trust0407,900 00Against
AQR0398,000 00Against
JPMorgan0352,000 00Against
Lazard0337,500 00Against
Ashmore Funds0327,706 00Against
Empower0323,000 00Against
GuideStone0263,500 00Against
Franklin Templeton0245,983 00Against
MASTER INVESTMENT PORTFOLIO93,000144,000 00Mixed
AIG/SunAmerica0235,000 00Against
Lincoln Financial0154,500 00Against

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

25. To consider and receive the audited consolidated financial statements of the company and the reports of directors and…

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 14 asset managers

Description as filed by funds: TO CONSIDER AND RECEIVE THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY AND THE REPORTS OF DIRECTORS AND THE AUDITOR OF THE COMPANY FOR THE YEAR ENDED DECEMBER 31, 2025

The 14 asset managers below reported 18,019,583 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 18,019,583
Largest asset managers voting on “TO CONSIDER AND RECEIVE THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY AND THE REPORTS OF DIRECT” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,300,0000 00For
BlackRock1,699,0000 00For
BAILLIE GIFFORD FUNDS1,330,5000 00For
Krane Shares Trust593,5000 00For
John Hancock338,5210 00For
Touchstone ETF Trust224,8740 00For
Jackson National219,5000 00For
Roundhill ETF Trust193,5000 00For
SP Funds Trust28,6000 00For
Rayliant Funds Trust25,3620 00For
WILSHIRE MUTUAL FUNDS INC23,5000 00For
Amplify ETF Trust20,0000 00For
Innovator ETFs Trust17,5000 00For
GPS Funds I5,2260 00For

26. To re-appoint Deloitte Touche tohmatsu as auditor of the company and authorise the board to fix their remuneration

No official resultsAUDIT-RELATED

96% of fund votes cast · no official result

FOR
Details: description as filed, votes by 14 asset managers

Description as filed by funds: TO RE-APPOINT DELOITTE TOUCHE TOHMATSU AS AUDITOR OF THE COMPANY AND AUTHORISE THE BOARD TO FIX THEIR REMUNERATION

The 14 asset managers below reported 17,222,336 for, 797,247 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 17,222,336AGAINST: 797,247
Largest asset managers voting on “TO RE-APPOINT DELOITTE TOUCHE TOHMATSU AS AUDITOR OF THE COMPANY AND AUTHORISE THE BOARD TO FIX THEIR REMUNERA” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard13,300,0000 00For
BlackRock1,676,00023,000 00For
BAILLIE GIFFORD FUNDS1,330,5000 00For
Krane Shares Trust593,5000 00For
John Hancock0338,521 00Against
Touchstone ETF Trust224,8740 00For
Jackson National0219,500 00Against
Roundhill ETF Trust0193,500 00Against
SP Funds Trust28,6000 00For
Rayliant Funds Trust25,3620 00For
WILSHIRE MUTUAL FUNDS INC23,5000 00For
Amplify ETF Trust20,0000 00For
Innovator ETFs Trust017,500 00Against
GPS Funds I05,226 00Against

27. Appointment of Auditor and Authority to Set Fees

No official resultsAUDIT-RELATED

100% of fund votes cast · no official result

FOR
Details: votes by 8 asset managers

The 8 asset managers below reported 11,143,750 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 11,143,750
Largest asset managers voting on “Appointment of Auditor and Authority to Set Fees” at Innovent Biologics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford5,258,9000 00For
Prudential/PGIM2,316,5280 00For
Charles Schwab1,922,3220 00For
Fidelity1,150,0000 00For
Russell Investments400,0000 00For
SEI44,5000 00For
Venerable Variable Insurance Trust39,5000 00For
Neuberger Berman12,0000 00For

Largest Innovent Biologics, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.

Fund voting reports: top Innovent Biologics, Inc. shareholders by shares voted on “Accept Financial Statements and Statutory Reports”, 2025-2026
#Asset manager Shares voted
1Vanguard 51,616,086
2BlackRock 29,200,500
3Capital Group 23,425,873
4EUPAC FUND 20,115,000
5Fidelity 18,936,825
6American Century 3,619,000
7TIAA 2,552,310
8State Street 2,512,000
9MATTHEWS INTERNATIONAL FUNDS 1,547,000
10Dimensional 1,341,000

Shown as share counts, not percentages: no shares-outstanding figure has been matched to Innovent Biologics, Inc. for the 2025-2026 season, so there is no denominator to divide by.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

Innovent Biologics, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).

Cite this page

proxyvotesnow.com, “Innovent Biologics, Inc. 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/innovent-biologics-inc/2026 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.